Wave Life Sciences Ltd. (WVE) — Financial statements
Income statement, balance sheet, and cash flow for Wave Life Sciences Ltd. — annual and quarterly history with growth and margin analysis.
| Metric (USD Millions) | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
| Revenue & Gross Profit | ||||||
| Revenue | 43↓60.5% | 108↓4.4% | 113↑3005.1% | 4↓91.1% | 41 | |
| Cost of Revenue | 9 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Gross Profit | 34↓68.7% | 108↓4.4% | 113↑3005.1% | 4↓91.1% | 41 | |
| Operating Expenses | ||||||
| R&D Expenses | 183↑14.5% | 160↑22.8% | 130↑12.2% | 116↓4.9% | 122 | |
| General & Administrative Expenses | 75↑27.6% | 59↑15.1% | 51↑1.5% | 51↑9.6% | 46 | |
| Selling & Marketing Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| SG&A Expenses | 75↑27.6% | 59↑15.1% | 51↑1.5% | 51↑9.6% | 46 | |
| Other Expenses | -9 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Operating Expenses | 249↑14.0% | 219↑20.6% | 181↑9.0% | 166↓1.0% | 168 | |
| Total Costs & Expenses | 258↑18.0% | 219↑20.6% | 181↑9.0% | 166↓1.0% | 168 | |
| Operating Results | ||||||
| Operating Income | -215↓95.1% | -110↓62.4% | -68↑58.2% | -163↓28.1% | -127 | |
| Depreciation & Amortization | 9↑2.2% | 9↓5.9% | 9↓9.0% | 10↑2.8% | 10 | |
| EBITDA | -196↓92.2% | -102↓73.1% | -59↑61.5% | -153↓30.2% | -117 | |
| EBIT | -204↓85.1% | -110↓62.4% | -68↑58.2% | -163↓28.1% | -127 | |
| Interest & Other Income | ||||||
| Net Interest Income | 10 | 0.00 | 0.00 | 0.00↓100.0% | 0.03 | |
| Interest Income | 10 | 0.00 | 0.00 | 0.00↓100.0% | 0.03 | |
| Interest Expense | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Non-Operating Income | -11 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Other Income / Expenses | 11↓17.8% | 13↑36.6% | 10↑521.4% | 2↓65.4% | 5 | |
| Income Before Tax | -204↓110.7% | -97↓66.7% | -58↑63.9% | -161↓31.6% | -122 | |
| Income Tax Expense | 0.00 | 0.00↑100.0% | -0.68↓199.4% | 0.68↑433.8% | -0.20 | |
| Net Income & EPS | ||||||
| Net Income from Continuing Operations | -204↓110.7% | -97↓68.7% | -58↑64.5% | -162↓32.4% | -122 | |
| Net Income from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Income | -204↓110.7% | -97↓68.7% | -58↑64.5% | -162↓32.4% | -122 | |
| Bottom-Line Net Income | -204↓110.7% | -97↓68.7% | -58↑64.5% | -162↓32.4% | -122 | |
| EPS (Basic) | -1.21↓72.9% | -0.70↓29.6% | -0.54↑73.7% | -2.05↑13.1% | -2.36 | |
| EPS (Diluted) | -1.21↓72.9% | -0.70↓29.6% | -0.54↑73.7% | -2.05↑13.1% | -2.36 | |
| Weighted Average Shares | 169↑22.0% | 138↑30.3% | 106↑34.5% | 79↑52.2% | 52 | |
| Weighted Average Diluted Shares | 169↑22.0% | 138↑30.3% | 106↑34.5% | 79↑52.2% | 52 | |
* All figures in Millions of USD, except per share data. Growth rates calculated Year-over-Year (YoY). Data source: SEC Filings.